Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.2B | 983M | 844M | 939M |
Cost of revenue | 28M | 28M | 32M | 33M |
Gross profit | 1.2B | 955M | 812M | 906M |
Operating expense | ||||
Research & development | 546M | 533M | 507M | 485M |
Selling general and admin | 257M | 247M | 241M | 239M |
Other operating expenses | — | — | — | — |
Operating income | 410M | 175M | 64M | 182M |
Non operating interest income | ||||
Income | 27M | 28M | 29M | 32M |
Expense | — | — | — | — |
Other income expense | -293M | 65M | -29M | 30M |
Pretax income | 144M | 268M | 64M | 244M |
Tax provision | -66M | 16M | -43M | 21M |
Net income | 210M | 252M | 107M | 223M |
Basic EPS | — | 0.2 | 0.1 | 0.2 |
Diluted EPS | — | 0.2 | 0.1 | 0.2 |
Basic average shares | — | 1.1B | 1.0B | 1.0B |
Diluted average shares | — | 1.1B | 1.1B | 1.1B |
EBITDA | 749M | 183M | 118M | 201M |
Net income from continuing op. | 210M | 252M | 107M | 223M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |